Inhibition of B Cell Receptor-Mediated B Cell Activation and IgE secretion by Coengagement of Surface IgE and FcγRIIb with Fc-Engineered Antibodies
David E. Szymkowski(Xencor (United States)), John R. Desjarlais(Xencor (United States)), Holly Horton(Xencor (United States)), Erik Pong(Xencor (United States)), Jonathan Zalevsky(Nektar Therapeutics (United States)), Herry Herman(Xencor (United States)), Seung Y. Chu(Xencor (United States))
Cited by 0
Related Papers
β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2
|The Journal of Cell Biology|2000|816
Enhanced antibody half-life improves in vivo activity
|Nature Biotechnology|2010|654
JNK and Tumor Necrosis Factor-α Mediate Free Fatty Acid-induced Insulin Resistance in 3T3-L1 Adipocytes
|Journal of Biological Chemistry|2005|403